Posted in Awareness, Cardiovascular Sciences, Prevention, Research and Funding, clinical trials • Tags: cardiology, clinical trials, studies
In the arena of drug development, cardiovascular medicine is no longer the favorite therapeutic area. This is according to a study published in the August issue of Nature, which analyzed the number of clinical trials registered at ClinicalTrials registery during the last two years, as reported by heartwire. Cardiology, which used to occupy the top priority position in research and development in the pharmaceutical industry, only now ranked 3rd. The top two places are occupied by cancer oncolgy and neurodegenerative medicine, respectively. This is despite the fact that lipid regulators which brought in US$ 35.2 billion worth of drug sales in 2006. The complete list of the six highest-ranked therapeutic/disease areas is given below:
- Oncology
- CNS disorders
- Cardiology
- Infectious diseases
- Endocrinology
- Respiratory diseases
More →
Posted on November 18, 2008 by Raquel Billiones • There are no comments, hop to it!
Posted in Blood Pressure, Cardiovascular Sciences, Drug Therapy, High Blood Pressure, Hypertension Heart Disease, Medications • Tags: clinical trials, hypertension, testing, vaccine
You’ve heard of vaccines against polio, measles, small pox. What about a vaccine against hypertension? Last year, a paper presented at the American Heart Association Scientific Sessions reported about an investigational vaccine against angiotensin II. Angiotensin II is a vasoconstrictor agent - it causes constriction of blood vessels leading to increase in blood pressure. When a vaccine is investigational, it is still being tested and not yet ready for use.
However, this vaccine being tested by Cytos Biotechnology seems to be promising.
More →
Posted on September 18, 2008 by Raquel Billiones • There are no comments, hop to it!